Table of contents
From January 8th, Liverpool will host the world’s foremost fertility experts at the prestigious Fertility 2025 congress. This global event, a benchmark in the field of assisted reproduction, serves as a platform for advancing the science of fertility. As every year, Tambre is proudly participating, reaffirming its commitment to research excellence and innovation in reproductive medicine.
This year’s congress, themed “Reproduction: Facts, Myths, and Evidence,” features Tambre professionals presenting two groundbreaking scientific studies aimed at enhancing the understanding and outcomes of fertility treatments.
Contributing to the Scientific Dialogue
Representing Tambre at Fertility 2025 are senior embryologist Carolina Andrés, scientific advisor José Antonio Horcajadas, and CEO Inge Kormelink. Their presentations will offer attendees exclusive insights into pioneering research, which opens new horizons in reproductive medicine.
The studies, presented in poster format, invite in-depth discussion among global experts and focus on critical aspects of embryonic development and sperm selection technologies enhanced by artificial intelligence. These findings push the boundaries of scientific understanding, aiming to improve patient outcomes.
Study 1
Does a Lower-Quality Embryo from Donor Eggs Have Higher Implantation Potential than a Higher-Quality Embryo from the Patient’s Own Eggs?
Tambre’s researchers have explored the relationship between embryo quality and oocyte origin, examining whether lower-quality embryos from donor oocytes may offer higher implantation potential than higher-quality embryos derived from a patient’s own eggs. This work provides valuable insights into optimizing assisted reproduction strategies, enabling patients to achieve pregnancy more efficiently with evidence-based approaches.
Does a poorer quality embryo from donor oocytes have a higher implantation potential than a better quality embryo from a patient’s oocytes? C. Andrés, S. Alfaro, C. Cordero, C. Rodríguez, Á. Almoyna, R. Pandolfi, G. Domínguez, S. Díez, M. Manzanares, L. Ortega, J.A. Horcajadas, S. Cortés
Study 2
Morphokinetic Study of Embryo Development Based on Sperm Selection Methods Using CHLOE as an Artificial Intelligence (AI) Analysis Tool
This study delves into the impact of various sperm selection techniques on embryonic development and implantation potential, leveraging the advanced capabilities of the CHLOE AI system—a Tambre innovation. By comparing the Swim-Up, Sperm-Slow, and Zymot-ICSI methods, the research identifies the most effective techniques for improving embryo quality and clinical success rates.
Morphokinetic study of embryo development based on sperm selection method using CHLOE as an artificial intelligence (AI) analysis tool. C. Andrés, L. Serrano, C. Cordero, C. Rodríguez, Á. Almoyna, S. Ruiz, R. García, S. Díez, M. Manzanares, L. Ortega, N. Bergelson, J. A. Horcajadas, S. Cortés
A Dynamic and Inspiring Event
Fertility 2025 offers a vibrant environment for knowledge exchange, professional networking, and the introduction of transformative research. For Tambre, it is an invaluable opportunity to cement its leadership in reproductive medicine.
By participating in such prestigious events, Tambre continues to ensure that every patient benefits from personalized care driven by cutting-edge advancements. The congress underscores Tambre’s dedication to continuous improvement, innovation, and a steadfast commitment to helping individuals achieve their dreams of parenthood.
Pioneering Research Through Collaboration
Tambre’s active presence at Fertility 2025 reflects its relentless pursuit of scientific progress, a mission supported by the Tambre Foundation. Through collaborations with universities and international experts, the foundation plays a pivotal role in ensuring Tambre remains at the forefront of reproductive medicine.
Together, Shaping the Future of Fertility
Fertility 2025 symbolizes a collective passion for advancing fertility care. Tambre is honored to contribute to this global community of experts working tirelessly to transform lives. With research, collaboration, and patient-centered care at its core, Tambre continues to lead the way in reproductive medicine—ensuring that every individual has access to the most effective and innovative treatments.
This week, Liverpool becomes a hub for groundbreaking ideas, bringing hope to countless families. At Tambre, we are proud to stand among the world’s leading fertility experts, united by a shared vision of making parenthood possible.
